
Magellan Health, Inc. MGLN
Magellan Health, Inc. ROE Ratio 2011-2026 | MGLN
Annual ROE Ratio Magellan Health, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 20.45 | 4.0 | 1.88 | 8.63 | 7.08 | 2.95 | 7.0 | 10.83 | 14.85 | 15.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.45 | 1.88 | 9.3 |
ROE Ratio of other stocks in the Health care industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
12.9 | - | -2.32 % | $ 107 B | ||
|
Cigna Corporation
CI
|
9.21 | $ 291.61 | -1.06 % | $ 79.8 B | ||
|
CVS Health Corporation
CVS
|
2.35 | $ 78.8 | 2.31 % | $ 99.8 B | ||
|
Triple-S Management Corporation
GTS
|
6.94 | - | 0.28 % | $ 847 M | ||
|
Humana
HUM
|
7.37 | $ 178.45 | 1.74 % | $ 21.5 B | ||
|
Centene Corporation
CNC
|
12.51 | $ 39.49 | -2.33 % | $ 20.6 B | ||
|
Molina Healthcare
MOH
|
11.6 | $ 127.01 | 3.55 % | $ 6.71 B | ||
|
NovoCure Limited
NVCR
|
-46.82 | $ 13.29 | 26.57 % | $ 1.43 B | ||
|
UnitedHealth Group Inc.
UNH
|
14.66 | $ 281.33 | 0.87 % | $ 259 B |